144 related articles for article (PubMed ID: 15767802)
1. Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1): potential basis for a new therapeutic approach.
Moinfar F; Gogg-Kamerer M; Sommersacher A; Regitnig P; Man YG; Zatloukal K; Denk H; Tavassoli FA
Am J Surg Pathol; 2005 Apr; 29(4):485-9. PubMed ID: 15767802
[TBL] [Abstract][Full Text] [Related]
2. Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains.
Bhargava R; Shia J; Hummer AJ; Thaler HT; Tornos C; Soslow RA
Mod Pathol; 2005 Jan; 18(1):40-7. PubMed ID: 15309019
[TBL] [Abstract][Full Text] [Related]
3. Expression of androgen receptors in benign and malignant endometrial stromal neoplasms.
Moinfar F; Regitnig P; Tabrizi AD; Denk H; Tavassoli FA
Virchows Arch; 2004 May; 444(5):410-4. PubMed ID: 15007645
[TBL] [Abstract][Full Text] [Related]
4. Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors.
Jakate K; Azimi F; Ali RH; Lee CH; Clarke BA; Rasty G; Shaw PA; Melnyk N; Huntsman DG; Laframboise S; Rouzbahman M
Mod Pathol; 2013 Jan; 26(1):95-105. PubMed ID: 22918161
[TBL] [Abstract][Full Text] [Related]
5. Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas.
Kurihara S; Oda Y; Ohishi Y; Kaneki E; Kobayashi H; Wake N; Tsuneyoshi M
Mod Pathol; 2010 Feb; 23(2):225-34. PubMed ID: 19898427
[TBL] [Abstract][Full Text] [Related]
6. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
[TBL] [Abstract][Full Text] [Related]
7. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations.
Croce S; Hostein I; Ribeiro A; Garbay D; Velasco V; Stoeckle E; Guyon F; Floquet A; Neuville A; Coindre JM; MacGrogan G; Chibon F
Mod Pathol; 2013 Oct; 26(10):1390-400. PubMed ID: 23599159
[TBL] [Abstract][Full Text] [Related]
8. Transition from low-grade endometrial stromal sarcoma to high-grade endometrial stromal sarcoma.
Ohta Y; Suzuki T; Omatsu M; Hamatani S; Shiokawa A; Kushima M; Ota H
Int J Gynecol Pathol; 2010 Jul; 29(4):374-7. PubMed ID: 20567152
[TBL] [Abstract][Full Text] [Related]
9. Endometrial stromal sarcomas: immunoprofile with emphasis on HMB45 reactivity.
Albores-Saavedra J; Dorantes-Heredia R; Chablé-Montero F; Chanona-Vilchis J; Pérez-Montiel D; Lino-Silva LS; González-Romo MA; Ramírez-Jaramillo JM; Henson DE
Am J Clin Pathol; 2014 Jun; 141(6):850-5. PubMed ID: 24838330
[TBL] [Abstract][Full Text] [Related]
10. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
[TBL] [Abstract][Full Text] [Related]
11. Analysis of epidermal growth factor receptor (EGFR) status in endometrial stromal sarcoma.
Capobianco G; Pili F; Contini M; De Miglio MR; Marras V; Santeufemia DA; Cherchi C; Dessole M; Cherchi PL; Cossu-Rocca P
Eur J Gynaecol Oncol; 2012; 33(6):629-32. PubMed ID: 23327060
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors.
Jung CK; Jung JH; Lee A; Lee YS; Choi YJ; Yoon SK; Lee KY
Mod Pathol; 2008 Jun; 21(6):756-63. PubMed ID: 18376386
[TBL] [Abstract][Full Text] [Related]
13. Low-grade endometrial stromal sarcoma: hormonal aspects.
Chu MC; Mor G; Lim C; Zheng W; Parkash V; Schwartz PE
Gynecol Oncol; 2003 Jul; 90(1):170-6. PubMed ID: 12821359
[TBL] [Abstract][Full Text] [Related]
14. Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement.
Lee CH; Hoang LN; Yip S; Reyes C; Marino-Enriquez A; Eilers G; Tao D; Chiang S; Fletcher JA; Soslow RA; Nucci MR; Oliva E
Mod Pathol; 2014 May; 27(5):751-7. PubMed ID: 24186140
[TBL] [Abstract][Full Text] [Related]
15. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
[TBL] [Abstract][Full Text] [Related]
16. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.
Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H
Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480
[TBL] [Abstract][Full Text] [Related]
17. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
[TBL] [Abstract][Full Text] [Related]
18. Myxoid and fibrous endometrial stromal tumors of the uterus: a report of 10 cases.
Oliva E; Young RH; Clement PB; Scully RE
Int J Gynecol Pathol; 1999 Oct; 18(4):310-9. PubMed ID: 10542938
[TBL] [Abstract][Full Text] [Related]
19. Retroperitoneal low grade endometrial stromal sarcoma with florid endometrioid glandular differentiation: Cytologic-histologic correlation and differential diagnosis.
Abdelkader A; Giorgadze T
Ann Diagn Pathol; 2019 Apr; 39():25-29. PubMed ID: 30611894
[TBL] [Abstract][Full Text] [Related]
20. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas.
Reich O; Regauer S; Urdl W; Lahousen M; Winter R
Br J Cancer; 2000 Mar; 82(5):1030-4. PubMed ID: 10737385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
